CEREFUZE MEDICAL
LIVE

Serial Number

98420471

Owner

Cerefuze Medical LTD.

Attorney

ESTEBAN O'FARRELL

Filing Date

Feb 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CEREFUZE MEDICAL Trademark

Serial Number: 98420471 • Registration: 7693310

CEREFUZE MEDICAL is a trademark filed by Cerefuze Medical LTD. on February 26, 2024. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cerefuze Medical LTD. (2 trademarks)

Curragh House, Briarhill
Galway H91RXY9 , IE

Entity Type: 99

Trademark Details

Filing Date

February 26, 2024

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Medical services; Medical treatment of acute ischemic stroke; Medical treatment of cerebral ischemic reperfusion injury (IRI) post mechanical thrombectomy; Providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the Internet

Medical devices for use in treating acute ischemic stroke; Medical devices for use in treating cerebral ischemic reperfusion injury (IRI) post mechanical thrombectomy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2024 CRFA
ASSIGNED TO LIE
Dec 3, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 17, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 23, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 23, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 23, 2024 CNSL
ASSIGNED TO EXAMINER
Sep 13, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 2, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2024 NWOS
NEW APPLICATION ENTERED
Feb 26, 2024 NWAP